Shin A. Lee

Hashima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group.

Real-world comparison of brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone and anthracycline-based regimens in peripheral T-cell lymphoma: A multicenter retrospective study from the Gifu Hematology Study Group.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: July 30, 2026

Real-world outcome and dose intensity of Pola-R-CHP versus R-CHOP/R-THP-COP in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective cohort study.

Real-world outcome and dose intensity of Pola-R-CHP versus R-CHOP/R-THP-COP in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective cohort study.

Journal: BMC cancer

Published: October 29, 2025

Clinical Impact of the Geriatric Nutritional Risk Index on Chemotherapy-Related Adverse Events in Diffuse Large B-Cell Lymphoma: A Multicenter Study.

Clinical Impact of the Geriatric Nutritional Risk Index on Chemotherapy-Related Adverse Events in Diffuse Large B-Cell Lymphoma: A Multicenter Study.

Journal: Nutrients

Published: October 16, 2025

A Comparison of the Risk of Viral Load Blips in Human Immunodeficiency Virus Patients on Two-Drug Versus Three-Drug Antiretroviral Regimens.

A Comparison of the Risk of Viral Load Blips in Human Immunodeficiency Virus Patients on Two-Drug Versus Three-Drug Antiretroviral Regimens.

Journal: Infectious disease reports

Published: August 09, 2025

Impact of a nudge-based intervention on hand soap usage in a Japanese Hospital: interrupted time series analysis.

Impact of a nudge-based intervention on hand soap usage in a Japanese Hospital: interrupted time series analysis.

Journal: Infection prevention in practice

Published: July 15, 2025

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

Journal: Annals of hematology

Published: July 13, 2025

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Journal: Hematological oncology

Published: May 21, 2025

Impact of the acute national blood culture bottle shortage on the two-set blood culture rate in a single center in Japan: Insights from an interrupted time-series analysis.

Impact of the acute national blood culture bottle shortage on the two-set blood culture rate in a single center in Japan: Insights from an interrupted time-series analysis.

Journal: Infection prevention in practice

Published: May 15, 2025

Age interaction in associations between geriatric nutritional risk index and prognosis in diffuse large B-cell lymphoma.

Age interaction in associations between geriatric nutritional risk index and prognosis in diffuse large B-cell lymphoma.

Journal: Annals of hematology

Published: April 21, 2025

Myelodysplastic syndrome initially presenting as thrombotic microangiopathy-like rapid cytopenia with schistocytes.

Myelodysplastic syndrome initially presenting as thrombotic microangiopathy-like rapid cytopenia with schistocytes.

Journal: The Lancet. Haematology

Published: December 22, 2024

Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma.

Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphoma.

Journal: Annals of hematology

Published: May 17, 2024

The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.

The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: December 21, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026